Last update 01 Nov 2024

4-1BBL x 5T4

Basic Info

Related Targets
4-1BBL5T4

Related

1
Drugs associated with 4-1BBL x 5T4
FTL-008.16
Target
4-1BBL x 5T4
Mechanism
4-1BBL modulators [+1]
Active Org.
Sound Biopharmaceuticals Ltd.Sound Biopharmaceuticals Ltd.
Originator Org.
Sound Biopharmaceuticals Ltd.Sound Biopharmaceuticals Ltd.
Active Indication
Advanced Malignant Solid Neoplasm [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with 4-1BBL x 5T4
NCT06410131 / Not yet recruitingPhase 1
A Phase 1, First-in-Human, Open-Label, Dose Escalation and Dose Expansion Study of FTL008.16, a Recombinant Anti-CD137 and Anti-5T4 Bispecific Antibody, in Patients With Advanced or Metastatic Solid Tumors
100 Clinical Results associated with 4-1BBL x 5T4
Login to view more data
100 Translational Medicine associated with 4-1BBL x 5T4
Login to view more data
0 Patents (Medical) associated with 4-1BBL x 5T4
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free